30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

Company Revenue 2015: Aurora Spine

$0.9MM, +102% (U.S. $0.8MM, ex-U.S. $0.06MM)

  • TiNano® interbody portfolio ~$0.5MM (TiNano Discover cervical interbody cage sales +183%)
  • Increased salesforce in central U.S.
  • Initiated surgeries with VOX™ LLIF and EOS™ TLIF systems
  • 1st implant of ZIP ULTRA™ interspinous device in Switzerland
  • 1st U.S. and ex-U.S. implants of ZIP 51™ Minimally Invasive Interspinous device
  • Completed 2 private placements for net proceeds of ~$3.4MM, to support general working capital


Remaining 2015 initiatives include:

  • North American expansion, including new V.P. of U.S. Sales
  • Growth of TiNano portfolio